Jonathan Zung, Ph.D.
Jonathan Zung, Ph.D. assumed his role as president, Clintrax and advisor to CEO WCG in June 2018. Jonathan is an experienced industry executive with more than 25 years of pharmaceutical development experience in oncology, immunology, cardiovascular disease and other major therapeutic areas. He has held executive leadership positions in the pharmaceutical and pharmaceutical services industries.
Most recently, Jonathan was group president, Clinical Development & Commercialization Services for Covance Drug Development where he led a global organization of over 8,000 employees in 60 countries spanning all phases of development (Phase I- IV), along with global market access services.
Prior to Covance Jonathan was vice president and head of Global Clinical Sciences and Operations at UCB, with responsibility for clinical operations, data management, statistical sciences, contracting, medical writing and operational excellence across the United States, Europe and Asia. Before joining UCB, he was vice president and head of Global Development Operations at Bristol-Myers Squibb, where he led a 1,400-person organization that managed clinical trials from Phase II through registration. He also held several positions of increasing responsibility at Pfizer Global Research and Development.
Jonathan is a member of the board of directors of the Clinical Data Interchange Standards Consortium (CDISC). Previously, he served as chair of the TransCelerate BioPharma operations committee from 2013-2015 and served as a member of The Florida Institute of Technology Board of Trustees from 2010- 2016. He received his doctorate in analytical chemistry from Emory University in Atlanta, Georgia and has a bachelor’s degree in chemistry from the Florida Institute of Technology in Melbourne, Florida.
Vice President of Grants Management
Russell is responsible for leading the Grants Management Department which includes the Global Investigator Payments division as well as the Budget Development division. He brings over 9 years of research experience at the University, Investigator Site and CRO levels to Clintrax.
Prior to Clintrax, Russell worked at a large international CRO where he led a team responsible for global proposal and budget development for a large volume of Phase I-IV clinical trials across a multitude of therapeutic indications. He collaborated with multi-functional global teams and Sponsors to execute projects from the bid stage through trial start-up, as well as providing on-going analysis of negotiated contracts vs. bid projections throughout the payments process to ensure projects were within scope.
Prior to this, Russell was responsible for establishing a start-up clinical research partnership with a cardiology practice, successfully training medical staff on ICH-GCP compliance, securing and negotiating new trials, and recruiting patients for enrollment. He has also worked for a prominent CRO as an in-house monitor and as a graduate research and teaching assistant at Youngstown State University while completing Master’s coursework in Biology. In addition, Russell earned his BS in Life Science Education from Youngstown State.